Plasma riche en plaquettes, 4 séances

Efficacité

• Amélioration marquée
  11,25 % face à Plasma riche en plaquettes, 4 séances + Procapil 5 %
  26 semaines · écart probablement réel · Khoso 2024
  Voir la citation

  Similarly, based on Dermatologist evaluation 11.25%,16.25% & 30% in Group A and 15%, 23,75% & 38.75% of patients in Group B were in the Excellent, Moderate and Slight Hair regrowth range respectively (p-value=0.0069), Figure-3.

  Citation complémentaire (inclusion)

  All male patients with hair loss (Hamilton score II -V), between the ages 18–50 years and willing to undergo the procedure were included in this study

  Citation complémentaire (methode)

  syringes were used to inject it intradermally. Group A received four sessions of PRP 4 weeks apart while group B received the same therapy in combination with 5% topical Procapil solution,5 puffs twice a day for 6 months. Basic demographic

  Khoso H, Fahim M. Comparison of platelet rich therapy alone with platelet rich therapy along with daily topical 5% procapil application for the treatment of androgenetic alopecia. Journal of Ayub Medical College Abbottabad 2024, DOI 10.55519/JAMC-02-12749. Citation sous licence CC-BY-ND.

• Densité capillaire totale activé, séances hebdomadaires
  sans valeur publiée face à Placebo
  30 semaines · écart probablement réel · Tawfik 2018
  Voir la citation

  Results: There was a statistical significant difference between PRP and placebo areas(P<.005)regardingbothhairdensityandhairthicknessasmeasuredbyafollis-

  Tawfik AA, Osman MAR. The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study. Journal of Cosmetic Dermatology 2018, DOI 10.1111/jocd.12357. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

• Diamètre de la tige pilaire activé, séances hebdomadaires
  sans valeur publiée face à Placebo
  30 semaines · écart probablement réel · Tawfik 2018
  Voir la citation

  Results: There was a statistical significant difference between PRP and placebo areas(P<.005)regardingbothhairdensityandhairthicknessasmeasuredbyafollis-

  Tawfik AA, Osman MAR. The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study. Journal of Cosmetic Dermatology 2018, DOI 10.1111/jocd.12357. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

• Patients améliorés (évaluation investigateur) intralésionnel, séances mensuelles
  73 % face à Triamcinolone intralésionnel, concentration non précisée
  16 semaines · écart probablement réel · Khan 2022
  Voir la citation

  Efficacy among two groups revealed that 27 (90%) patients of Group A had effective treatment response (p<0.05) while 3 (10%) of patients didn’t show marked improvement. In Group B 22 (73%) showed effective response (p=0.05) while 8 (27%) patients didn’t show significant improvement to the treatment.

  Citation complémentaire (inclusion)

  Patients with mild to moderate alopecia areata of both sexes were included in the study. Their age limit was ranging from 14 to 25 years. Before participating in the study patients were off the J Ayub Med Coll Abbottabad 2022;34(4) treatment for about three months, i.e., from February 2021. Alopecia areata is defined as three or fewer patches of alopecia with a diameter of at least 3 cm. Moderate alopecia areata is the presence of more than three patches or patches greater than 3cm diameter without alopecia totalis or alopecia universalis.7

  Citation complémentaire (methode)

  Photographs were taken before and after 4,8,12, and 16 weeks of treatment in order to assess treatment response and to compare efficacy between intralesional injection of triamcinolone and platelet rich plasma. In each follow-up, the percentage of hair regrowth was assessed by using SALT SCORE.

  Khan FA, Hussain M, Khan BM et al.. Comparative study between intralesional injection of platelet rich plasma and intra lesional triamcinolone for the treatment of alopecia areata. Journal of Ayub Medical College Abbottabad 2022. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

• Patients améliorés (évaluation investigateur) pelade legere, score de severite 1 a 2 intralésionnel, séances mensuelles
  11 patients face à Triamcinolone intralésionnel, concentration non précisée
  16 semaines · écart qui peut être dû au hasard · Khan 2022
  Voir la citation

  Table-2: Stratification of efficacy with respect to severity score Severity score Efficacy Group A Group B *p-value 1-2 (mild) Effective 15 11 0.1224 Not effective 1 4 Total 16 15 3-4 (moderate) Effective 12 11 0.4108 Not effective 2 4 Total 14 15

  Citation complémentaire (inclusion)

  Patients with mild to moderate alopecia areata of both sexes were included in the study. Their age limit was ranging from 14 to 25 years. Before participating in the study patients were off the J Ayub Med Coll Abbottabad 2022;34(4) treatment for about three months, i.e., from February 2021. Alopecia areata is defined as three or fewer patches of alopecia with a diameter of at least 3 cm. Moderate alopecia areata is the presence of more than three patches or patches greater than 3cm diameter without alopecia totalis or alopecia universalis.7

  Citation complémentaire (methode)

  Photographs were taken before and after 4,8,12, and 16 weeks of treatment in order to assess treatment response and to compare efficacy between intralesional injection of triamcinolone and platelet rich plasma. In each follow-up, the percentage of hair regrowth was assessed by using SALT SCORE.

  Khan FA, Hussain M, Khan BM et al.. Comparative study between intralesional injection of platelet rich plasma and intra lesional triamcinolone for the treatment of alopecia areata. Journal of Ayub Medical College Abbottabad 2022. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

• Patients améliorés (évaluation investigateur) pelade moderee, score de severite 3 a 4 intralésionnel, séances mensuelles
  11 patients face à Triamcinolone intralésionnel, concentration non précisée
  16 semaines · écart qui peut être dû au hasard · Khan 2022
  Voir la citation

  Table-2: Stratification of efficacy with respect to severity score Severity score Efficacy Group A Group B *p-value 1-2 (mild) Effective 15 11 0.1224 Not effective 1 4 Total 16 15 3-4 (moderate) Effective 12 11 0.4108 Not effective 2 4 Total 14 15

  Citation complémentaire (inclusion)

  Patients with mild to moderate alopecia areata of both sexes were included in the study. Their age limit was ranging from 14 to 25 years. Before participating in the study patients were off the J Ayub Med Coll Abbottabad 2022;34(4) treatment for about three months, i.e., from February 2021. Alopecia areata is defined as three or fewer patches of alopecia with a diameter of at least 3 cm. Moderate alopecia areata is the presence of more than three patches or patches greater than 3cm diameter without alopecia totalis or alopecia universalis.7

  Citation complémentaire (methode)

  Photographs were taken before and after 4,8,12, and 16 weeks of treatment in order to assess treatment response and to compare efficacy between intralesional injection of triamcinolone and platelet rich plasma. In each follow-up, the percentage of hair regrowth was assessed by using SALT SCORE.

  Khan FA, Hussain M, Khan BM et al.. Comparative study between intralesional injection of platelet rich plasma and intra lesional triamcinolone for the treatment of alopecia areata. Journal of Ayub Medical College Abbottabad 2022. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

• Patients en amélioration légère (échelle médecin, +1)
  30 % face à Plasma riche en plaquettes, 4 séances + Procapil 5 %
  26 semaines · écart probablement réel · Khoso 2024
  Voir la citation

  Similarly, based on Dermatologist evaluation 11.25%,16.25% & 30% in Group A and 15%, 23,75% & 38.75% of patients in Group B were in the Excellent, Moderate and Slight Hair regrowth range respectively (p-value=0.0069), Figure-3.

  Citation complémentaire (inclusion)

  All male patients with hair loss (Hamilton score II -V), between the ages 18–50 years and willing to undergo the procedure were included in this study

  Citation complémentaire (methode)

  syringes were used to inject it intradermally. Group A received four sessions of PRP 4 weeks apart while group B received the same therapy in combination with 5% topical Procapil solution,5 puffs twice a day for 6 months. Basic demographic

  Khoso H, Fahim M. Comparison of platelet rich therapy alone with platelet rich therapy along with daily topical 5% procapil application for the treatment of androgenetic alopecia. Journal of Ayub Medical College Abbottabad 2024, DOI 10.55519/JAMC-02-12749. Citation sous licence CC-BY-ND.

• Patients en amélioration modérée (échelle médecin, +2)
  16,25 % face à Plasma riche en plaquettes, 4 séances + Procapil 5 %
  26 semaines · écart probablement réel · Khoso 2024
  Voir la citation

  Similarly, based on Dermatologist evaluation 11.25%,16.25% & 30% in Group A and 15%, 23,75% & 38.75% of patients in Group B were in the Excellent, Moderate and Slight Hair regrowth range respectively (p-value=0.0069), Figure-3.

  Citation complémentaire (inclusion)

  All male patients with hair loss (Hamilton score II -V), between the ages 18–50 years and willing to undergo the procedure were included in this study

  Citation complémentaire (methode)

  syringes were used to inject it intradermally. Group A received four sessions of PRP 4 weeks apart while group B received the same therapy in combination with 5% topical Procapil solution,5 puffs twice a day for 6 months. Basic demographic

  Khoso H, Fahim M. Comparison of platelet rich therapy alone with platelet rich therapy along with daily topical 5% procapil application for the treatment of androgenetic alopecia. Journal of Ayub Medical College Abbottabad 2024, DOI 10.55519/JAMC-02-12749. Citation sous licence CC-BY-ND.

• Patients légèrement satisfaits
  25 % face à Plasma riche en plaquettes, 4 séances + Procapil 5 %
  26 semaines · écart probablement réel · Khoso 2024
  Voir la citation

  More than 47% of patients had positive family history. After 6 months 25%,13.75% and 10% of patients in Group A were in the Slight, Moderate and very satisfactory range. On the other hand, in Group B the Slight, Moderate and very satisfactory categories consisted of 35% 23.75% and 13.75% patients (p-value=0.0022), Figure-2.

  Citation complémentaire (inclusion)

  All male patients with hair loss (Hamilton score II -V), between the ages 18–50 years and willing to undergo the procedure were included in this study

  Citation complémentaire (methode)

  syringes were used to inject it intradermally. Group A received four sessions of PRP 4 weeks apart while group B received the same therapy in combination with 5% topical Procapil solution,5 puffs twice a day for 6 months. Basic demographic

  Khoso H, Fahim M. Comparison of platelet rich therapy alone with platelet rich therapy along with daily topical 5% procapil application for the treatment of androgenetic alopecia. Journal of Ayub Medical College Abbottabad 2024, DOI 10.55519/JAMC-02-12749. Citation sous licence CC-BY-ND.

• Patients moyennement satisfaits
  13,75 % face à Plasma riche en plaquettes, 4 séances + Procapil 5 %
  26 semaines · écart probablement réel · Khoso 2024
  Voir la citation

  More than 47% of patients had positive family history. After 6 months 25%,13.75% and 10% of patients in Group A were in the Slight, Moderate and very satisfactory range. On the other hand, in Group B the Slight, Moderate and very satisfactory categories consisted of 35% 23.75% and 13.75% patients (p-value=0.0022), Figure-2.

  Citation complémentaire (inclusion)

  All male patients with hair loss (Hamilton score II -V), between the ages 18–50 years and willing to undergo the procedure were included in this study

  Citation complémentaire (methode)

  syringes were used to inject it intradermally. Group A received four sessions of PRP 4 weeks apart while group B received the same therapy in combination with 5% topical Procapil solution,5 puffs twice a day for 6 months. Basic demographic

  Khoso H, Fahim M. Comparison of platelet rich therapy alone with platelet rich therapy along with daily topical 5% procapil application for the treatment of androgenetic alopecia. Journal of Ayub Medical College Abbottabad 2024, DOI 10.55519/JAMC-02-12749. Citation sous licence CC-BY-ND.

• Patients sans réponse au traitement intralésionnel, séances mensuelles
  27 % face à Triamcinolone intralésionnel, concentration non précisée
  16 semaines · Khan 2022
  Voir la citation

  Efficacy among two groups revealed that 27 (90%) patients of Group A had effective treatment response (p<0.05) while 3 (10%) of patients didn’t show marked improvement. In Group B 22 (73%) showed effective response (p=0.05) while 8 (27%) patients didn’t show significant improvement to the treatment.

  Citation complémentaire (inclusion)

  Patients with mild to moderate alopecia areata of both sexes were included in the study. Their age limit was ranging from 14 to 25 years. Before participating in the study patients were off the J Ayub Med Coll Abbottabad 2022;34(4) treatment for about three months, i.e., from February 2021. Alopecia areata is defined as three or fewer patches of alopecia with a diameter of at least 3 cm. Moderate alopecia areata is the presence of more than three patches or patches greater than 3cm diameter without alopecia totalis or alopecia universalis.7

  Citation complémentaire (methode)

  Photographs were taken before and after 4,8,12, and 16 weeks of treatment in order to assess treatment response and to compare efficacy between intralesional injection of triamcinolone and platelet rich plasma. In each follow-up, the percentage of hair regrowth was assessed by using SALT SCORE.

  Khan FA, Hussain M, Khan BM et al.. Comparative study between intralesional injection of platelet rich plasma and intra lesional triamcinolone for the treatment of alopecia areata. Journal of Ayub Medical College Abbottabad 2022. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

• Patients très satisfaits
  10 % face à Plasma riche en plaquettes, 4 séances + Procapil 5 %
  26 semaines · écart probablement réel · Khoso 2024
  Voir la citation

  More than 47% of patients had positive family history. After 6 months 25%,13.75% and 10% of patients in Group A were in the Slight, Moderate and very satisfactory range. On the other hand, in Group B the Slight, Moderate and very satisfactory categories consisted of 35% 23.75% and 13.75% patients (p-value=0.0022), Figure-2.

  Citation complémentaire (inclusion)

  All male patients with hair loss (Hamilton score II -V), between the ages 18–50 years and willing to undergo the procedure were included in this study

  Citation complémentaire (methode)

  syringes were used to inject it intradermally. Group A received four sessions of PRP 4 weeks apart while group B received the same therapy in combination with 5% topical Procapil solution,5 puffs twice a day for 6 months. Basic demographic

  Khoso H, Fahim M. Comparison of platelet rich therapy alone with platelet rich therapy along with daily topical 5% procapil application for the treatment of androgenetic alopecia. Journal of Ayub Medical College Abbottabad 2024, DOI 10.55519/JAMC-02-12749. Citation sous licence CC-BY-ND.

• Test de traction devenu négatif activé, séances hebdomadaires
  83 % (25 sur 30)
  30 semaines · Tawfik 2018
  Voir la citation

  cope. The hair pull test became negative in PRP-injected areas in 25 patients (83%)

  Tawfik AA, Osman MAR. The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study. Journal of Cosmetic Dermatology 2018, DOI 10.1111/jocd.12357. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).